Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
5.52
-0.24 (-4.17%)
Mar 3, 2026, 4:00 PM EST - Market closed
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $323.37 million as of March 4, 2026. Its market cap has decreased by -5.60% in one year.
Market Cap
323.37M
Enterprise Value
165.62M
1-Year Change
-5.60%
Ranking
Category
Stock Price
$5.52
Market Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $323.37M, a decrease of -42.81%. That is a compound annual growth rate of -9.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 337.43M | 10.50% |
| Dec 31, 2025 | 305.38M | 16.38% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Relmada Therapeutics | 354.93M |
| Aldeyra Therapeutics | 338.23M |
| Climb Bio | 337.55M |
| Sutro Biopharma | 336.69M |
| Avalo Therapeutics | 332.86M |
| Puma Biotechnology | 326.63M |
| Rezolute | 326.16M |
| XOMA Royalty | 324.56M |